OpenBilldrug price receipt

NADAC week of 2026-10-14

FLUOXETINE HCL 20 MG CAPSULE

For 30 capsules

Pharmacies pay

$0.88 filed

30 × $0.02932 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$4.89 filed

30 × $0.16289 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

5.6× estimated

Medicare paid 5.6× what pharmacies pay.

Part D averages every strength and form sold under “Fluoxetine HCl” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$6.01 estimated

$0.88 + $0.13 (15%) + $5.00 fee per fill = $6.01

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

FLUOXETINE HCL 20 MG CAPSULE is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “fluoxetine” and “fluoxetine hydrochloride”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as capsule and its route as oral.

FDA lists 12 labelers (the companies named on the label) for its NDCs, among them Major Pharmaceuticals, NorthStar Rx LLC and Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

FDA’s Established Pharmacologic Class for it is Serotonin Reuptake Inhibitor.

The NADAC file of 2026-10-14 prices it under 30 NDCs (National Drug Codes); the FDA directory lists 28 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $0.88 for 30 capsules (30 × $0.02932 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 12 labelers

LabelerNDCsPharmacies pay per unit
Aurobindo Pharma Limited4$0.02932 per EA filed
BluePoint Laboratories4$0.02932 per EA filed
Teva Pharmaceuticals USA, Inc.4$0.02932 per EA filed
NorthStar Rx LLC3$0.02932 per EA filed
Alembic Pharmaceuticals Inc.2$0.02932 per EA filed
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.2$0.02932 per EA filed
Modavar Pharmaceuticals LLC2$0.02932 per EA filed
ScieGen Pharmaceuticals, Inc.2$0.02932 per EA filed
TIME CAP LABORATORIES, INC.2$0.02932 per EA filed
Legacy Pharmaceutical Packaging, LLC1$0.02932 per EA filed
Major Pharmaceuticals1$0.02932 per EA filed
QUALLENT PHARMACEUTICALS HEALTH LLC1$0.02932 per EA filed
Not listed as a package in the FDA directory2$0.02932 per EA filed
All 30 NDCs, with labeler and price
  • 00904-7346-61 · Major Pharmaceuticals · $0.02932 per EA · eff. 2026-09-23 filed
  • 16714-0721-02 · NorthStar Rx LLC · $0.02932 per EA · eff. 2026-09-23 filed
  • 16714-0721-03 · NorthStar Rx LLC · $0.02932 per EA · eff. 2026-09-23 filed
  • 23155-0029-01 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. · $0.02932 per EA · eff. 2026-09-23 filed
  • 23155-0029-10 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. · $0.02932 per EA · eff. 2026-09-23 filed
  • 49483-0702-01 · TIME CAP LABORATORIES, INC. · $0.02932 per EA · eff. 2026-09-23 filed
  • 49483-0702-10 · TIME CAP LABORATORIES, INC. · $0.02932 per EA · eff. 2026-09-23 filed
  • 50111-0648-01 · Teva Pharmaceuticals USA, Inc. · $0.02932 per EA · eff. 2026-09-23 filed
  • 50111-0648-02 · Teva Pharmaceuticals USA, Inc. · $0.02932 per EA · eff. 2026-09-23 filed
  • 50111-0648-03 · Teva Pharmaceuticals USA, Inc. · $0.02932 per EA · eff. 2026-09-23 filed
  • 50111-0648-44 · Teva Pharmaceuticals USA, Inc. · $0.02932 per EA · eff. 2026-09-23 filed
  • 50228-0114-01 · ScieGen Pharmaceuticals, Inc. · $0.02932 per EA · eff. 2026-09-23 filed
  • 50228-0114-10 · ScieGen Pharmaceuticals, Inc. · $0.02932 per EA · eff. 2026-09-23 filed
  • 59651-0899-00 · Aurobindo Pharma Limited · $0.02932 per EA · eff. 2026-09-23 filed
  • 59651-0899-99 · Aurobindo Pharma Limited · $0.02932 per EA · eff. 2026-09-23 filed
  • 62332-0023-31 · Alembic Pharmaceuticals Inc. · $0.02932 per EA · eff. 2026-09-23 filed
  • 62332-0023-91 · Alembic Pharmaceuticals Inc. · $0.02932 per EA · eff. 2026-09-23 filed
  • 65862-0193-01 · Aurobindo Pharma Limited · $0.02932 per EA · eff. 2026-09-23 filed
  • 65862-0193-99 · Aurobindo Pharma Limited · $0.02932 per EA · eff. 2026-09-23 filed
  • 68001-0400-00 · BluePoint Laboratories · $0.02932 per EA · eff. 2026-09-23 filed
  • 68001-0400-08 · BluePoint Laboratories · $0.02932 per EA · eff. 2026-09-23 filed
  • 68001-0671-00 · BluePoint Laboratories · $0.02932 per EA · eff. 2026-09-23 filed
  • 68001-0671-08 · BluePoint Laboratories · $0.02932 per EA · eff. 2026-09-23 filed
  • 68645-0130-54 · Legacy Pharmaceutical Packaging, LLC · $0.02932 per EA · eff. 2026-09-23 filed
  • 69367-0236-01 · not listed as a package in the FDA directory · $0.02932 per EA · eff. 2026-09-23 filed
  • 69367-0236-10 · not listed as a package in the FDA directory · $0.02932 per EA · eff. 2026-09-23 filed
  • 72241-0008-05 · Modavar Pharmaceuticals LLC · $0.02932 per EA · eff. 2026-09-23 filed
  • 72241-0008-11 · Modavar Pharmaceuticals LLC · $0.02932 per EA · eff. 2026-09-23 filed
  • 72603-0489-02 · NorthStar Rx LLC · $0.02932 per EA · eff. 2026-09-23 filed
  • 82009-0101-10 · QUALLENT PHARMACEUTICALS HEALTH LLC · $0.02932 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

7 other products in the NADAC file share an FDA nonproprietary name with FLUOXETINE HCL 20 MG CAPSULE.

ProductPharmacies pay per unitMedicare per unit
FLUOXETINE 20 MG/5 ML SOLUTION
generic · for solution / liquid / solution
$0.20327 per ML filed
eff. 2026-09-23
We don’t know yet
FLUOXETINE DR 90 MG CAPSULE
generic · capsule, delayed release pellets
$30.68175 per EA filed
eff. 2026-09-23
$26.33388 per EA filed
Part D 2024 average
FLUOXETINE HCL 10 MG CAPSULE
generic · capsule
$0.03529 per EA filed
eff. 2026-09-23
$0.16289 per EA filed
Part D 2024 average
FLUOXETINE HCL 10 MG TABLET
generic · tablet / tablet, film coated / tablet, coated
$0.06978 per EA filed
eff. 2026-09-23
$0.16289 per EA filed
Part D 2024 average
FLUOXETINE HCL 20 MG CAPSULE this page
generic · capsule
$0.02932 per EA filed
eff. 2026-09-23
$0.16289 per EA filed
Part D 2024 average
FLUOXETINE HCL 20 MG TABLET
generic · tablet / tablet, film coated / tablet, coated
$0.08383 per EA filed
eff. 2026-09-23
$0.16289 per EA filed
Part D 2024 average
FLUOXETINE HCL 40 MG CAPSULE
generic · capsule
$0.05186 per EA filed
eff. 2026-09-23
$0.16289 per EA filed
Part D 2024 average
FLUOXETINE HCL 60 MG TABLET
generic · tablet, film coated / tablet
$0.18175 per EA filed
eff. 2026-09-23
$0.16289 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 30 NDCs’ NADAC prices is $0.02932 per EA filed.

Of the 58 other products in FDA’s Serotonin Reuptake Inhibitor class priced per EA, 56 have a higher middle NADAC price and 2 a lower one. The one in the middle is TRAZODONE 300 MG TABLET, at $0.49767 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $4.89 for 30 capsules, at an average of $0.16289 per EA in 2024 (2024-01-01 to 2024-12-31) for “Fluoxetine HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 7,481,805 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for FLUOXETINE HCL 20 MG CAPSULE labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Fluoxetine HCl / Fluoxetine HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name. 144 of 150 NADAC NDCs joined to this name are priced per EA (6 per ML): CMS's average mixes those units.